Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Alnylam Reports Positive Topline Results from KARDIA-1 Phase 2 Dose-Ranging Study of Zilebesiran, an Investigational RNAi Therapeutic in Development to Treat Hypertension in Patients at High Cardiovascular Risk
09/07/2023

 Alnylam Pharmaceuticals News

 Alnylam Pharmaceuticals News
The KARDIA-1 Phase 2 trial is a randomized, double-blind (DB), placebo-controlled, multi-center global dose-ranging study designed to evaluate the efficacy and safety of zilebesiran as monotherapy in adults with mild-to-moderate hypertension.
The KARDIA-1 Phase 2 trial is a randomized, double-blind (DB), placebo-controlled, multi-center global dose-ranging study designed to evaluate the efficacy and safety of zilebesiran as monotherapy in adults with mild-to-moderate hypertension.
The KARDIA-1 Phase 2 trial is a...
09/07/2023
Cath Lab Digest
News
For Patients With Diabetes, Being Divorced and Male Increases Risk of Lower Limb Amputation
09/07/2023

European Association for the Study of Diabetes (EASD) News

European Association for the Study of...
Among people with type 1 and type 2 diabetes, being divorced is associated with a two-thirds higher risk of lower limb amputation (LLA) (amputations below the knee level) compared with being married, and being male is associated with a 57%...
Among people with type 1 and type 2 diabetes, being divorced is associated with a two-thirds higher risk of lower limb amputation (LLA) (amputations below the knee level) compared with being married, and being male is associated with a 57%...
Among people with type 1 and...
09/07/2023
Cath Lab Digest
News
AHA: High Blood Pressure While Lying Down Linked to Higher Risk of Heart Health Complications
09/07/2023

American Heart Association Hypertension Scientific Session News

American Heart Association Hypertensi...
“If blood pressure is only measured while people are seated upright, cardiovascular disease risk may be missed if not measured also while they are lying supine on their backs,” said lead study author Duc M. Giao.
“If blood pressure is only measured while people are seated upright, cardiovascular disease risk may be missed if not measured also while they are lying supine on their backs,” said lead study author Duc M. Giao.
“If blood pressure is only...
09/07/2023
Cath Lab Digest

Advertisement

News
MedAxiom, Wharton Online Expand Partnership to Shape Future Cardiovascular Business Leaders
09/07/2023

American College of Cardiology News

American College of Cardiology News ...
The Business Essentials for Cardiovascular Fellows Program focuses on the non-clinical competencies of healthcare operations, economics, change leadership and people management. 
The Business Essentials for Cardiovascular Fellows Program focuses on the non-clinical competencies of healthcare operations, economics, change leadership and people management. 
The Business Essentials for...
09/07/2023
Cath Lab Digest
News
Mayo Clinic Study: Stress Test Abnormalities Reveal More Than Just Cardiovascular Risks
09/07/2023

Mayo Clinic News

Mayo Clinic News
A recent study from Mayo Clinic finds that exercise test abnormalities, such as low functional aerobic capacity, predicted non-cardiovascular death in addition to cardiovascular-related deaths.
A recent study from Mayo Clinic finds that exercise test abnormalities, such as low functional aerobic capacity, predicted non-cardiovascular death in addition to cardiovascular-related deaths.
A recent study from Mayo Clinic...
09/07/2023
Cath Lab Digest
News
Latest-Generation Watchman FLX Pro Left Atrial Appendage Closure Device Now FDA Approved
09/07/2023

Boston Scientific Corporation News

Boston Scientific Corporation News ...
The latest WATCHMAN FLX Pro device is enhanced with a coating designed to reduce device-related thrombus and enable faster, controlled healing and endothelization of the device surface.
The latest WATCHMAN FLX Pro device is enhanced with a coating designed to reduce device-related thrombus and enable faster, controlled healing and endothelization of the device surface.
The latest WATCHMAN FLX Pro...
09/07/2023
Cath Lab Digest

Advertisement

News
Mount Sinai Announces Partnership With the Brazilian Clinical Research Institute to Advance Cardiovascular Disease Research and Medical Education
09/06/2023

Mount Sinai News

Mount Sinai News
New York, NY – The Icahn School of Medicine at Mount Sinai announced that it has signed a memorandum of understanding with the Brazilian Clinical Research Institute (BCRI) to focus on advancing cardiovascular disease research, innovation, and...
New York, NY – The Icahn School of Medicine at Mount Sinai announced that it has signed a memorandum of understanding with the Brazilian Clinical Research Institute (BCRI) to focus on advancing cardiovascular disease research, innovation, and...
New York, NY – The Icahn School...
09/06/2023
Cath Lab Digest
News
Red Blood Cells Exposed to Oxygen Deficiency Protect Against Myocardial Infarction
09/05/2023

Karolinska Institutet News

Karolinska Institutet News
"The results show both that the red blood cells convey protection against injury in the heart in the event of low oxygen levels, and how that protection can be enhanced through a simple dietary advice. This may be of great importance for...
"The results show both that the red blood cells convey protection against injury in the heart in the event of low oxygen levels, and how that protection can be enhanced through a simple dietary advice. This may be of great importance for...
"The results show both that the...
09/05/2023
Cath Lab Digest
News
Study: Redo Transcatheter Aortic Valve Replacement Proven Effective, Safe
09/05/2023

Cedars-Sinai News

Cedars-Sinai News
Cedars-Sinai investigators have shown that redo transcatheter aortic valve replacement (TAVR) procedures are both safe and effective when compared with situations in which patients with similar risk profiles undergo the same procedure for the...
Cedars-Sinai investigators have shown that redo transcatheter aortic valve replacement (TAVR) procedures are both safe and effective when compared with situations in which patients with similar risk profiles undergo the same procedure for the...
Cedars-Sinai investigators have...
09/05/2023
Cath Lab Digest

Advertisement

News
Ohio State First in World to Participate in Trial of Device Designed to Alleviate Heart Failure Symptoms
08/31/2023

Ohio State News

Ohio State News
Ohio State’s Richard M. Ross Heart Hospital will continue to recruit patients in the randomized, double blinded study (ALT-FLOW II Trial of the Edwards APTURE Transcatheter Shunt System [ALT-FLOW II]).
Ohio State’s Richard M. Ross Heart Hospital will continue to recruit patients in the randomized, double blinded study (ALT-FLOW II Trial of the Edwards APTURE Transcatheter Shunt System [ALT-FLOW II]).
Ohio State’s Richard M. Ross...
08/31/2023
Cath Lab Digest

Advertisement

Advertisement

Subscriber

Cath Lab Digest Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use